Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.

Abstract:

:The essential role of prolactin (PRL) in normal mammary gland growth and differentiation has implicated this hormone in the development and progression of breast cancer. Although Stat5 is the best-characterized mediator of PRL signals, PRL also activates multiple other signals, whose roles in normal and pathologic processes are not well understood. We have shown that PRL stimulates activating protein-1 (AP-1) activity in breast cancer cells, and can cooperate with estradiol in this pathway. AP-1 modulates many processes critical for carcinogenesis, including cell proliferation, survival, transformation, invasion and angiogenesis, and is elevated in many neoplasms, including breast tumors. Here, we investigated the relationship between PRL signals to AP-1 and Stat5. We found that PRL activation of Stat5a and Stat5b, but not Stat1 or Stat3, reduced PRL signals to AP-1, without altering estradiol-induced AP-1 activity. The truncation mutant, Stat5/Delta53C, but not Stat5Y699F, was an effective inhibitor, consistent with a requirement for Stat5 dimerization and nuclear accumulation, but not its C-terminal transactivation activity. The association of Stat5 with AP-1 proteins suggests that this underlies the inhibition. Predictably, the ability of PRL to activate Stat5 and AP-1 was inversely related in mammary cell lines. Further, reduction of Stat5 protein with siRNA in T47D cells, which contain elevated Stat5, increased PRL-induced AP-1 signals, transcripts for the AP-1 target, matrix metalloproteinase-2 and associated invasive behavior. This study points to the importance of cell context in determining the spectrum of PRL-induced actions, which is critical for understanding the contributions of PRL to breast cancer.

journal_name

Oncogene

journal_title

Oncogene

authors

Gutzman JH,Rugowski DE,Nikolai SE,Schuler LA

doi

10.1038/sj.onc.1210454

subject

Has Abstract

pub_date

2007-09-20 00:00:00

pages

6341-8

issue

43

eissn

0950-9232

issn

1476-5594

pii

1210454

journal_volume

26

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling.

    abstract::Tumor metastasis, but not primary overgrowth, is the leading cause of mortality for cancer patients. During the past decade, Drosophila melanogaster has been well-accepted as an excellent model to address the intrinsic mechanism of different aspects of cancer progression, ranging from tumor initiation to metastasis. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.463

    authors: Ma X,Huang J,Tian Y,Chen Y,Yang Y,Zhang X,Zhang F,Xue L

    更新日期:2017-06-01 00:00:00

  • Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma.

    abstract::Squamous cell carcinoma (SCC) of the skin represents a group of neoplasms which is associated with exposure to UV light. Recently, we obtained data suggesting that invasive skin cancer and its precursors derive from one original neoplastic clone. Here, the analysis were extended by loss of heterozygosity (LOH) analysi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202080

    authors: Ahmadian A,Ren ZP,Williams C,Pontén F,Odeberg J,Pontén J,Uhlén M,Lundeberg J

    更新日期:1998-10-08 00:00:00

  • DNA double strand break repair and chromosomal translocation: lessons from animal models.

    abstract::The maintenance of genomic stability is one of the most important defenses against neoplastic transformation. This objective must be accomplished despite a constant barrage of spontaneous DNA double strand breaks. These dangerous lesions are corrected by two primary pathways of double strand break repair; non homologo...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204767

    authors: Ferguson DO,Alt FW

    更新日期:2001-09-10 00:00:00

  • Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.

    abstract::Ovarian cancer is currently the second leading cause of gynecological malignancy and cisplatin or cisplatin-based regimens have been the standard of care for the treatment of advance epithelial ovarian cancers. However, the efficacy of cisplatin treatment is often limited by the development of drug resistance either t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209836

    authors: Leong CT,Ong CK,Tay SK,Huynh H

    更新日期:2007-02-08 00:00:00

  • Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate.

    abstract::Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological role of these dual genetic alterations in prostate tumorigenesis is largely unknown. In addition, there...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0901-8

    authors: He Y,Johnson DT,Yang JS,Wu H,You S,Yoon J,Lee DH,Kim WK,Aldahl J,Le V,Hooker E,Yu EJ,Geradts J,Cardiff RD,Sun Z

    更新日期:2019-09-01 00:00:00

  • DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.

    abstract::DAL-1 (differentially expressed in adenocarcinoma of the lung)/4.1B is a tumor suppressor gene on human chromosome 18p11.3 whose expression is lost in >50% of primary non-small-cell lung carcinomas. Based on sequence similarity, DAL-1/4.1B has been assigned to the Protein 4.1 superfamily whose members interact with pl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208057

    authors: Singh V,Miranda TB,Jiang W,Frankel A,Roemer ME,Robb VA,Gutmann DH,Herschman HR,Clarke S,Newsham IF

    更新日期:2004-10-14 00:00:00

  • Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.

    abstract::The gene for von Recklinghausen neurofibromatosis type 1 (NF1) was recently identified by positional cloning and found to encode a protein with sequence similarity to a family of eucaryotic GTPase-activating proteins (GAPs). Expression of the NF1-GAP-related domain (NF1GRD) has been shown to complement yeast strains d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gutmann DH,Boguski M,Marchuk D,Wigler M,Collins FS,Ballester R

    更新日期:1993-03-01 00:00:00

  • THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

    abstract::Promyelocytic leukemia (PML) nuclear bodies (PML NBs) are discrete subnuclear domains organized by the promyelocytic leukemia protein PML, a tumor suppressor essential for multiple apoptotic pathways. We have recently described a novel family of cellular factors, the THAP proteins, characterized by the presence at the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206271

    authors: Roussigne M,Cayrol C,Clouaire T,Amalric F,Girard JP

    更新日期:2003-04-24 00:00:00

  • A raf/myc virus immortalized macrophage cell line which supports the growth of B-cell and B-cell hybridomas.

    abstract::Using a combination of raf and myc oncogenes co-expressed by the recombinant retrovirus J-2 we have generated and characterized a cell line which very efficiently supports the growth of B-cells and B-cell hybridomas. Murine spleen cells were cultured under in vitro immunization conditions favoring the short term proli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mischak H,Kolch W,Hofer F,Weissinger E,Gessl A,Davidson WF,Aiello FB,Blaas D,Rapp UR

    更新日期:1990-09-01 00:00:00

  • Tumour-suppression function of KLF12 through regulation of anoikis.

    abstract::Suppression of detachment-induced cell death, known as anoikis, is an essential step for cancer metastasis to occur. We report here that expression of KLF12, a member of the Kruppel-like family of transcription factors, is downregulated in lung cancer cell lines that have been selected to grow in the absence of cell a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.394

    authors: Godin-Heymann N,Brabetz S,Murillo MM,Saponaro M,Santos CR,Lobley A,East P,Chakravarty P,Matthews N,Kelly G,Jordan S,Castellano E,Downward J

    更新日期:2016-06-23 00:00:00

  • An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.

    abstract::Lineage-restricted transcription factors (TFs) are frequently mutated or overexpressed in cancer and contribute toward malignant behaviors; however, the molecular bases of their oncogenic properties are largely unknown. As TF activities are difficult to inhibit directly with small molecules, the genes and pathways the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.517

    authors: Sulahian R,Casey F,Shen J,Qian ZR,Shin H,Ogino S,Weir BA,Vazquez F,Liu XS,Hahn WC,Bass AJ,Chan V,Shivdasani RA

    更新日期:2014-12-04 00:00:00

  • Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.

    abstract::Most human lymphomas originate from transformed germinal center (GC) B lymphocytes. While activating mutations and translocations of MYC, BCL2 and BCL6 promote specific GC lymphoma subtypes, other genetic and epigenetic modifications that contribute to malignant progression in the GC remain poorly defined. Recently, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210211

    authors: Dawson DW,Hong JS,Shen RR,French SW,Troke JJ,Wu YZ,Chen SS,Gui D,Regelson M,Marahrens Y,Morse HC 3rd,Said J,Plass C,Teitell MA

    更新日期:2007-06-21 00:00:00

  • The erythropoietin-receptor pathway modulates survival of cancer cells.

    abstract::Anemia in cancer patients is associated with reduced quality of life and local failure after radiation treatment. However, the use of erythropoietin to correct cancer anemia and to improve radiation efficacy was disappointing. Erythropoietin-receptor signaling mainly acts via activation of STAT 5, but also crossactiva...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208140

    authors: Pajonk F,Weil A,Sommer A,Suwinski R,Henke M

    更新日期:2004-11-25 00:00:00

  • The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.

    abstract::As a result of the synovial sarcoma-associated t(X;18) translocation, the SS18 gene on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome. The SS18 protein is thought to act as a transcriptional co-activator, whereas the SSX proteins are thought to act as transcriptional co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210688

    authors: de Bruijn DR,van Dijk AH,Willemse MP,van Kessel AG

    更新日期:2008-01-24 00:00:00

  • Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.

    abstract::Cortactin, a p80/85 protein first identified as a src kinase substrate, is thought to be involved in the signaling pathway of mitogenic receptors and adhesion molecules mediating cytoskeletal reorganization. The cortactin gene, EMS1, maps to chromosome 11q13, a region amplified in head and neck squamous cell carcinoma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201850

    authors: Patel AS,Schechter GL,Wasilenko WJ,Somers KD

    更新日期:1998-06-25 00:00:00

  • Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.

    abstract::Despite the progress made in targeted anticancer therapies in recent years, challenges remain. The identification of new potential targets will ensure that the arsenal of cancer therapies continues to expand. FAM83B was recently discovered in a forward genetic screen for novel oncogenes that drive human mammary epithe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.293

    authors: Cipriano R,Bryson BL,Miskimen KL,Bartel CA,Hernandez-Sanchez W,Bruntz RC,Scott SA,Lindsley CW,Brown HA,Jackson MW

    更新日期:2014-06-19 00:00:00

  • Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice.

    abstract::LIM domain factors and associated cofactors are important developmental regulators in pattern formation and organogenesis. In addition, overexpression of two LIM-only factors (LMOs) causes acute lymphocytic leukemia. The more recently discovered LMO factor LMO4 is highly expressed in proliferating epithelial cells, an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207288

    authors: Wang N,Kudryavtseva E,Ch'en IL,McCormick J,Sugihara TM,Ruiz R,Andersen B

    更新日期:2004-02-26 00:00:00

  • The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.

    abstract::Inactivation of the tumor suppressor NF2/merlin underlies neurofibromatosis type 2 (NF2) and some sporadic tumors. Previous studies have established that merlin mediates contact inhibition of proliferation; however, the exact mechanisms remain obscure and multiple pathways have been implicated. We have previously repo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0883-6

    authors: Cui Y,Groth S,Troutman S,Carlstedt A,Sperka T,Riecken LB,Kissil JL,Jin H,Morrison H

    更新日期:2019-09-01 00:00:00

  • Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.

    abstract::The structure and expression of 14-3-3 sigma(sigma) was analysed in squamous carcinomas (SCC) of the vulva and in the vulval pre-malignant lesion vulval intraepithelial neoplasia (VIN). Sequence analysis of the sigma coding region did not detect mutations in any case of SCC or VIN III and loss of heterozygosity (LOH) ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205256

    authors: Gasco M,Sullivan A,Repellin C,Brooks L,Farrell PJ,Tidy JA,Dunne B,Gusterson B,Evans DJ,Crook T

    更新日期:2002-03-14 00:00:00

  • Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.

    abstract::Among surface molecules expressed on endothelial cells, endoglin (CD105) is emerging as a prime vascular target for antiangiogenetic cancer therapy. CD105 is a cell membrane glycoprotein mainly expressed on endothelial cells and overexpressed on tumor-associated vascular endothelium, which functions as an accessory co...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206813

    authors: Fonsatti E,Altomonte M,Nicotra MR,Natali PG,Maio M

    更新日期:2003-09-29 00:00:00

  • Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.

    abstract::Although transforming ras oncogenes have been implicated as causative factors in liver cell transformation, the exact function and phenotypic alterations generated by the expression of such transforming genes in liver epithelial cells has yet to be defined. We have utilized a retroviral vector system to deliver an ind...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Huber BE,Cordingley MG

    更新日期:1988-09-01 00:00:00

  • Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis.

    abstract::The angiogenic peptide adrenomedullin (ADM) has been implicated as a mediator of the increased risk of endometrial hyperplasia and cancer resulting from the use of tamoxifen for the treatment and prevention of breast cancer. ADM has been shown to be induced by tamoxifen in the endometrium and to be a growth factor for...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205374

    authors: Oehler MK,Hague S,Rees MC,Bicknell R

    更新日期:2002-04-25 00:00:00

  • Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.

    abstract::Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell rec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202411

    authors: Elly C,Witte S,Zhang Z,Rosnet O,Lipkowitz S,Altman A,Liu YC

    更新日期:1999-02-04 00:00:00

  • Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.

    abstract::Expression of polyomavirus middle-T antigen (middle-T) is involved in the formation of various tumors in vivo, e.g. hemangiomas and mammary gland tumors. Several genes have been shown to be activated in middle-T-expressing cells, but the underlying mechanisms have only been partially elucidated. Among the genes regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Besser D,Urich M,Sakaue M,Messerschmitt A,Ballmer-Hofer K,Nagamine Y

    更新日期:1995-12-07 00:00:00

  • The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.

    abstract::The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01477-8

    authors: Jessen C,Kreß JKC,Baluapuri A,Hufnagel A,Schmitz W,Kneitz S,Roth S,Marquardt A,Appenzeller S,Ade CP,Glutsch V,Wobser M,Friedmann-Angeli JP,Mosteo L,Goding CR,Schilling B,Geissinger E,Wolf E,Meierjohann S

    更新日期:2020-10-01 00:00:00

  • CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradation.

    abstract::Protein kinase CK2 is a ubiquitous and pleiotropic Ser/Thr protein kinase involved in cell growth and transformation. Here we report the identification by yeast interaction trap of a CK2 interacting protein, UBC3B, which is highly homologous to the E2 ubiquitin conjugating enzyme UBC3/CDC34. UBC3B complements the yeas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205574

    authors: Semplici F,Meggio F,Pinna LA,Oliviero S

    更新日期:2002-06-06 00:00:00

  • EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.

    abstract::EDD (E3 isolated by differential display), located at chromosome 8q22.3, is the human orthologue of the Drosophila melanogaster tumour suppressor gene 'hyperplastic discs' and encodes a HECT domain E3 ubiquitin protein-ligase. To investigate the possible involvement of EDD in human cancer, several cancers from diverse...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206775

    authors: Clancy JL,Henderson MJ,Russell AJ,Anderson DW,Bova RJ,Campbell IG,Choong DY,Macdonald GA,Mann GJ,Nolan T,Brady G,Olopade OI,Woollatt E,Davies MJ,Segara D,Hacker NF,Henshall SM,Sutherland RL,Watts CK

    更新日期:2003-08-07 00:00:00

  • Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation.

    abstract::EZH2 (enhancer of zeste homolog 2) is a critical enzymatic subunit of the polycomb repressive complex 2 (PRC2), which trimethylates histone H3 (H3K27) to mediate gene repression. Somatic mutations, overexpression and hyperactivation of EZH2 have been implicated in the pathogenesis of several forms of cancer. In partic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.571

    authors: Sahasrabuddhe AA,Chen X,Chung F,Velusamy T,Lim MS,Elenitoba-Johnson KS

    更新日期:2015-01-22 00:00:00

  • BAG-1 accelerates cell motility of human gastric cancer cells.

    abstract::BAG-1 is a Hsp70/Hsc70-binding protein that interacts with Bcl-2, Raf-1, steroid hormone receptors, Siah-1, and hepatocyte growth factor (HGF) receptors, implying multiple functions for the BAG-1 protein. Here, we provide evidence that gene transfer-mediated overexpression of BAG-1 markedly enhances the motility of hu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202661

    authors: Naishiro Y,Adachi M,Okuda H,Yawata A,Mitaka T,Takayama S,Reed JC,Hinoda Y,Imai K

    更新日期:1999-05-27 00:00:00

  • AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.

    abstract::The phosphatidylinositol 3-kinase (PI3K)/AKT and RAS oncogenic signalling modules are frequently mutated in sporadic human cancer. Although each of these pathways has been shown to play critical roles in driving tumour growth and proliferation, their activation in normal human cells can also promote cell senescence. A...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.394

    authors: Astle MV,Hannan KM,Ng PY,Lee RS,George AJ,Hsu AK,Haupt Y,Hannan RD,Pearson RB

    更新日期:2012-04-12 00:00:00